Medistim ASA (OSL:MEDI)

Market Cap	3.77B +34.0%
Revenue (ttm)	699.77M +25.8%
Net Income	159.21M +53.3%
EPS	8.71 +53.6%
Shares Out	18.28M
PE Ratio	23.65
Forward PE	24.31
Dividend	8.00 (3.88%)
Ex-Dividend Date	May 7, 2026

Volume	108,462
Average Volume	53,235
Open	203.00
Previous Close	203.00
Day's Range	198.00 - 208.00
52-Week Range	153.00 - 292.00
Beta	1.06
RSI	42.21
Earnings Date	Feb 27, 2026

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1984
• Employees: 154
• Stock Exchange: Oslo Børs
• Ticker Symbol: MEDI

Financial Performance

In 2025, Medistim ASA's revenue was 699.77 million, an increase of 25.82% compared to the previous year's 556.16 million. Earnings were 159.21 million, an increase of 53.33%.